144 related articles for article (PubMed ID: 6794975)
21. [Sensitivities of atypical mycobacteria to various drugs. IV. Sensitivities of atypical mycobacteria originally isolated in the U.S.A. to antituberculous drugs in triple combinations (author's transl)].
Kuze F; Naito Y; Takeda S; Maekawa N
Kekkaku; 1977 Oct; 52(10):505-13. PubMed ID: 599768
[No Abstract] [Full Text] [Related]
22. Novel mutations in ndh in isoniazid-resistant Mycobacterium tuberculosis isolates.
Lee AS; Teo AS; Wong SY
Antimicrob Agents Chemother; 2001 Jul; 45(7):2157-9. PubMed ID: 11408244
[TBL] [Abstract][Full Text] [Related]
23. [Bacteriostatic effects of sulfadimethoxine and kitasamycin on Mycobacterium avium-M. intracellulare complex].
Tsukamura M
Kekkaku; 1983 Apr; 58(4):247-50. PubMed ID: 6632486
[No Abstract] [Full Text] [Related]
24. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea.
Lee H; Cho SN; Bang HE; Lee JH; Bai GH; Kim SJ; Kim JD
Int J Tuberc Lung Dis; 2000 May; 4(5):441-7. PubMed ID: 10815738
[TBL] [Abstract][Full Text] [Related]
25. [Sensitivity "in vitro" of human tubercular mycobacteria and atypical mycobacteria to rifampicin].
Mandler F; Garimoldi M
G Ital Mal Torace; 1969; ():Suppl 2:7-13. PubMed ID: 4982435
[No Abstract] [Full Text] [Related]
26. [Sensitivities of atypical mycobacteria to various drugs. V. Sensitivities of Mycobacterium intracellulare to some aminoglycoside and peptide antibiotics (author's transl)].
Naito Y; Kuze F; Maekawa N
Kekkaku; 1979 Aug; 54(8):423-7. PubMed ID: 537304
[No Abstract] [Full Text] [Related]
27. The extreme sensitivity of Mycobacterium tuberculosis to the front-line antituberculosis drug isoniazid.
Deretic V; Pagán-Ramos E; Zhang Y; Dhandayuthapani S; Via LE
Nat Biotechnol; 1996 Nov; 14(11):1557-61. PubMed ID: 9634820
[TBL] [Abstract][Full Text] [Related]
28. [Antibacterial activity of Enviomycin for atypical mycobacteria. 2. Animal experiments (author's transl)].
Toyohara M
Kekkaku; 1979 Sep; 54(9):461-5. PubMed ID: 502153
[No Abstract] [Full Text] [Related]
29. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
[TBL] [Abstract][Full Text] [Related]
30. [Activity of the ansamycins LM 427 and FCE 22250 on atypical mycobacteria in vitro].
Ungheri D; Morvillo E; Sanfilippo A
G Ital Chemioter; 1983; 30(2-3):97-100. PubMed ID: 6329872
[No Abstract] [Full Text] [Related]
31. [Study on the molecular mechanism of multi-drug resistance in clinical isolates of Mycobacterium tuberculosis].
Wu X; Zhuang Y; Zhang J
Zhonghua Jie He He Hu Xi Za Zhi; 1997 Dec; 20(6):332-5. PubMed ID: 10374440
[TBL] [Abstract][Full Text] [Related]
32. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
Akselband Y; Cabral C; Shapiro DS; McGrath P
J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
[TBL] [Abstract][Full Text] [Related]
33. Molecular mechanisms of drug resistance in Mycobacterium tuberculosis clinical isolates.
Wu X; Zhang J; Zhuang Y; Zhang X; Li G; He X
Chin Med J (Engl); 1999 Jun; 112(6):524-8. PubMed ID: 11601331
[TBL] [Abstract][Full Text] [Related]
34. KatG sequence deletion is not the major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates.
Goto M; Oka S; Tachikawa N; Kitada K; Wada M; Abe C; Shimada K; Kimura S
Mol Cell Probes; 1995 Dec; 9(6):433-9. PubMed ID: 8808314
[TBL] [Abstract][Full Text] [Related]
35. [KatG Ser3 15Thr mutation as the main reason of isoniazid resistance in Mycobacterium tuberculosis isolated in the Novosibirsk and Kemerovo Regions].
Voronina EN; Vikhrova MA; Khrapov EA; Kinsht VN; Norkina OV; Gorbunova EV; Shabaldin AV; Glushkov AN; Krasnov VA; Filipenko ML
Mol Gen Mikrobiol Virusol; 2004; (3):8-11. PubMed ID: 15354935
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA.
Leung ET; Ho PL; Yuen KY; Woo WL; Lam TH; Kao RY; Seto WH; Yam WC
Antimicrob Agents Chemother; 2006 Mar; 50(3):1075-8. PubMed ID: 16495272
[TBL] [Abstract][Full Text] [Related]
37. [Sensitivities of atypical mycobacteria to various drugs. VI. Antibacterial effects of sulfonamides and their combinations in vitro].
Sakurai N; Kuze F
Kekkaku; 1983 Aug; 58(8):415-20. PubMed ID: 6663959
[No Abstract] [Full Text] [Related]
38. [The epidemiologic significance of the resistance of tuberculosis mycobacteria to isonicotinic acid hydrazide].
Margulis NIu; Vinogradova TI; Kusikova LM; Solomonova DE; Kerpel' RS
Probl Tuberk; 1971 Oct; 49(10):12-5. PubMed ID: 5004988
[No Abstract] [Full Text] [Related]
39. [Drug sensitivity of Mycobacterium fortuitum strains isolated from water samples].
Pelczarska B
Pneumonol Pol; 1982 Nov; 50(11):609-11. PubMed ID: 7182816
[No Abstract] [Full Text] [Related]
40. Use of fluorescence resonance energy transfer for rapid detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates.
Saribas Z; Yurdakul P; Alp A; Gunalp A
Int J Tuberc Lung Dis; 2005 Feb; 9(2):181-7. PubMed ID: 15732738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
